Previously treated cases tested for RR-/MDR-TB (%) in Panama
Panama: Previously treated cases tested for RR-/MDR-TB was 61.0% in 2022. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Panama, 2005–2022
Source: World Health Organization, Global Health Observatory.
Analysis
Panama recorded 61.0% for previously treated cases tested for rr-/mdr-tb in 2022.
That represents a change of down 10.3% on the previous year and up 1,748.5% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Panama peaked at 80.0% in 2019 and was at its lowest, 2.1%, in 2008.
Panama ranks 136th of 180 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Panama, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 19.0% | — |
| 2007 | 6.6% | -65.3% |
| 2008 | 2.1% | -68.2% |
| 2010 | 8.2% | +290.5% |
| 2011 | 25.0% | +204.9% |
| 2012 | 3.3% | -86.8% |
| 2013 | 49.0% | +1384.8% |
| 2014 | 26.0% | -46.9% |
| 2015 | 32.0% | +23.1% |
| 2016 | 36.0% | +12.5% |
| 2017 | 20.0% | -44.4% |
| 2018 | 47.0% | +135.0% |
| 2019 | 80.0% | +70.2% |
| 2021 | 68.0% | -15.0% |
| 2022 | 61.0% | -10.3% |
Panama compared with similar countries
- Panama's 61.0% is below the median for high income countries, which is 83.0%, 73% of the median. (57 countries reporting)
- Panama's 61.0% is below the median for Latin America & Caribbean, which is 85.0%, 72% of the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Panama changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2013 | +1384.8% | 3.3% | 49.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.2% | 2.1% | 19.0% | 3 |
| 2010s | 32.6% | 3.3% | 80.0% | 10 |
| 2020s | 64.5% | 61.0% | 68.0% | 2 |
Countries ranked near Panama
- 134 Madagascar 69.0% compare
- 135 Costa Rica 62.0% compare
- 136 Argentina 61.0% compare
- 136 Cuba 61.0% compare
- 136 Austria 61.0% compare
More health data for Panama
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5994 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,074 deaths per 1,000 people (2090)
- Number of infants who die before age 1 101 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -0.2522 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0378 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3451 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Panama?
- Previously treated cases tested for rr-/mdr-tb in Panama was 61.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Panama?
- The highest recorded value was 80.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Panama?
- The lowest recorded value was 2.1% in 2008.
- How does Panama rank for previously treated cases tested for rr-/mdr-tb?
- Panama ranks 136th out of 180 countries with data for 2022.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Panama?
- Over the last ten years it is up 1,748.5%. The long-run trend across the full record is volatile.
- Where does this Panama data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).